Stalevo: Clinical Trials

8 trials of Stalevo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown, 1 terminated, 1 withdrawn. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 4, Unknown 2, Terminated 1, Withdrawn 1

Follow Stalevo: new trials by email Literature Review of Stalevo trials Research Report on Stalevo

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease
levodopa/carbidopa/entacapone - Parkinson Disease
Phase 4UnknownSecond Affiliated Hospital of Soochow University602023-11-152024-02-01
Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease
Stalevo, Carbidopa and Levodopa Controlled Release Tablets - Parkinson Disease
Phase 4UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine1802022-01-012023-02-16
Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
carbidopa/levodopa, Carbidopa/Levodopa/Entacapone - Parkinson's Disease
Phase 4WithdrawnNovartis Pharmaceuticals2008-08-012012-04-30
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off
Carbidopa/levodopa/entacapone, Immediate release carbidopa/levodopa - Parkinson's Disease
Phase 4TerminatedNovartis142008-03-012011-02-18
Study to Evaluate Initiation of Stalevo in Early Wearing-off
Stalevo - Parkinson's Disease
Phase 4CompletedOrion Corporation, Orion Pharma1152006-09-012015-04-21
Stalevo in Early Wearing-Off Patients
Stalevo (levodopa/carbidopa/entacapone), Levodopa/carbidopa - Idiopathic Parkinson's Disease
Phase 4CompletedOrion Corporation, Orion Pharma2232005-08-012009-06-22
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
carbidopa, levodopa, entacapone - Parkinson's Disease
Phase 4CompletedNovartis1842005-07-012017-03-29
Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
Carbidopa/levodopa/entacapone - Parkinson's Disease With End of Dose Wearing Off
Phase 4CompletedNovartis Pharmaceuticals3592005-01-012017-03-30

Conditions studied

Parkinson Disease (8)  ·  Tremor (1)

Sponsors

Novartis (2)  ·  Novartis Pharmaceuticals (2)  ·  Orion Corporation, Orion Pharma (2)  ·  Second Affiliated Hospital of Soochow University (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

China (2)  ·  Germany (2)  ·  Sweden (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  Denmark (1)  ·  Finland (1)  ·  Ireland (1)  ·  Philippines (1)  ·  Puerto Rico (1)  ·  Taiwan (1)  ·  Thailand (1)

Top investigators

Andrew Wighton, BSc (Hons) (1)  ·  Bhadravati SD Sastry, FRCP (1)  ·  Chun-Feng Liu, MD,PhD (1)  ·  Wolfgang H. Oertel, Professor (1)